179 related articles for article (PubMed ID: 26037215)
1. Severe hydrocephalus caused by diffuse leptomeningeal and neurocutaneous melanocytosis of antenatal onset: a clinical, pathologic, and molecular study of 2 cases.
Uguen A; Laurent C; Samaison L; Boisselier B; Talagas M; Costa S; Aziza J; Mokhtari K; Le Maréchal C; Marcorelles P
Hum Pathol; 2015 Aug; 46(8):1189-96. PubMed ID: 26037215
[TBL] [Abstract][Full Text] [Related]
2. Neurocutaneous melanosis presenting with hydrocephalus. Case report and review of the literature.
Acosta FL; Binder DK; Barkovich AJ; Frieden IJ; Gupta N
J Neurosurg; 2005 Jan; 102(1 Suppl):96-100. PubMed ID: 16206742
[TBL] [Abstract][Full Text] [Related]
3. Metastatic peritoneal neurocutaneous melanocytosis.
Cajaiba MM; Benjamin D; Halaban R; Reyes-Múgica M
Am J Surg Pathol; 2008 Jan; 32(1):156-61. PubMed ID: 18162783
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of Clinical, Neuroimaging, and Cerebrospinal Fluid Features of Adult Neurocutaneous Melanocytosis.
Qian M; Ren H; Qu T; Lu Z; Zou Y; He J; Zhao Y; Chen L; Guan H
Eur Neurol; 2018; 80(1-2):1-6. PubMed ID: 30007971
[TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal melanocytosis in an adult male without large congenital nevi: a rare and atypical case of neurocutaneous melanosis.
Sutton BJ; Tatter SB; Stanton CA; Mott RT
Clin Neuropathol; 2011; 30(4):178-82. PubMed ID: 21726502
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of central nervous system abnormalities in neurocutaneous melanocytosis.
Ramaswamy V; Delaney H; Haque S; Marghoob A; Khakoo Y
Dev Med Child Neurol; 2012 Jun; 54(6):563-8. PubMed ID: 22469364
[TBL] [Abstract][Full Text] [Related]
7. Neurocutaneous Melanocytosis and Leptomeningeal Melanoma.
Mitre V; Heym K; Clark GD; Venkatramani R
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e195-e197. PubMed ID: 31764519
[TBL] [Abstract][Full Text] [Related]
8. Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis.
Salgado CM; Basu D; Nikiforova M; Hamilton RL; Gehris R; Jakacki R; Panigrahy A; Yatsenko S; Reyes-Múgica M
Melanoma Res; 2015 Oct; 25(5):453-60. PubMed ID: 26266759
[TBL] [Abstract][Full Text] [Related]
9. Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy.
Ruan Y; Kovalchuk A; Jayanthan A; Lun X; Nagashima Y; Kovalchuk O; Wright JR; Pinto A; Kirton A; Anderson R; Narendran A
Neuro Oncol; 2015 Jun; 17(6):822-31. PubMed ID: 25395461
[TBL] [Abstract][Full Text] [Related]
10. Progressive brainstem compression in an infant with neurocutaneous melanosis and Dandy-Walker complex following ventriculoperitoneal shunt placement for hydrocephalus. Case report.
McClelland S; Charnas LR; SantaCruz KS; Garner HP; Lam CH
J Neurosurg; 2007 Dec; 107(6 Suppl):500-3. PubMed ID: 18154021
[TBL] [Abstract][Full Text] [Related]
11. Neurocutaneous melanosis with hydrocephalus: report of one case.
Hsueh CW; Ho CS; Chiu NC; Shen EY
Acta Neurol Taiwan; 2004 Mar; 13(1):29-33. PubMed ID: 15315299
[TBL] [Abstract][Full Text] [Related]
12. A newborn with neurocutaneous melanocytosis and Dandy-Walker malformation.
De Cock J; Snauwaert J; Van Rompaey W; Morren MA; Demaerel P
Pediatr Neurol; 2014 Mar; 50(3):276-8. PubMed ID: 24321541
[TBL] [Abstract][Full Text] [Related]
13. [Melanocytic meningitis and large congenital melanocytic naevus: neurocutaneous melanosis].
Feuillet L; Kaphan E; Audoin B; Witjas T; Pelletier J; Pellissier JF; Ali Cherif A
Rev Neurol (Paris); 2003 Apr; 159(4):435-9. PubMed ID: 12773873
[TBL] [Abstract][Full Text] [Related]
14. Neurocutaneous melanocytosis (melanosis).
Ruggieri M; Polizzi A; Catanzaro S; Bianco ML; Praticò AD; Di Rocco C
Childs Nerv Syst; 2020 Oct; 36(10):2571-2596. PubMed ID: 33048248
[TBL] [Abstract][Full Text] [Related]
15. Leptomeningeal melanomatosis associated with neurocutaneous melanosis: an autopsy case report.
Matsumura M; Okudela K; Tateishi Y; Umeda S; Mitsui H; Suzuki T; Nakayama T; Inayama Y; Ohashi K
Pathol Int; 2015 Feb; 65(2):100-5. PubMed ID: 25521302
[TBL] [Abstract][Full Text] [Related]
16. Neurocutaneous melanocytosis presenting in a teenager: A case report and review of the literature.
Monica I; Kumar LP; Uppin MS; Jagannath Rao Naidu KV
J Cancer Res Ther; 2015; 11(3):649. PubMed ID: 26458618
[TBL] [Abstract][Full Text] [Related]
17. Neurocutaneous melanosis presenting with hydrocephalus and malignant transformation: case-based update.
Sharouf F; Zaben M; Lammie A; Leach P; Bhatti MI
Childs Nerv Syst; 2018 Aug; 34(8):1471-1477. PubMed ID: 29948137
[TBL] [Abstract][Full Text] [Related]
18. Neurocutaneous melanosis.
Di Rocco F; Sabatino G; Koutzoglou M; Battaglia D; Caldarelli M; Tamburrini G
Childs Nerv Syst; 2004 Jan; 20(1):23-8. PubMed ID: 14576958
[TBL] [Abstract][Full Text] [Related]
19. NRAS
Girolami I; Cima L; Ghimenton C; Zannoni M; Mombello A; Riva G; Cirielli V; Corradi G; Vogrig A; Di Stefano G; Novelli L; Gessi M; Eccher A
Brain Tumor Pathol; 2018 Oct; 35(4):217-223. PubMed ID: 30145692
[TBL] [Abstract][Full Text] [Related]
20. Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor.
Küsters-Vandevelde HV; Willemsen AE; Groenen PJ; Küsters B; Lammens M; Wesseling P; Djafarihamedani M; Rijntjes J; Delye H; Willemsen MA; van Herpen CM; Blokx WA
Acta Neuropathol Commun; 2014 Apr; 2():41. PubMed ID: 24713450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
